MYXMAYNE PHARMA GROUP LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 20 Aug 2026, 18:59 | Upcoming presentation of Imvexxy clinical data | Company Update | — | 11001 | |
| 18 Aug 2026, 19:16 | Mayne Pharma launches Investor Hub | Company Administration | — | 12008 | |
| 15 Aug 2026, 03:13 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 6 Aug 2026, 03:20 | Mayne Pharma Bioshares Summit Presentation | Presentations | — | 03026 | |
| 6 Aug 2026, 03:14 | Notification of cessation of securities - MYX | Other | — | 06027 | |
| 6 Aug 2026, 03:14 | Notification regarding unquoted securities - MYX | Other | — | 06021 | |
| 5 Aug 2026, 23:35 | Non-Executive Director appointment | Company Administration | — | 12001 | |
| 4 Aug 2026, 01:46 | Mayne Pharma to present at the 20th Bioshares Summit | Company Administration | — | 12008 | |
| 31 July 2026, 19:29 | Mayne Pharma reports unaudited Q4 and FY26 results | Periodic Reports | MS | 03014, 03027, 03028 | |
| 17 July 2026, 18:53 | Mayne Pharma appoints new Chief Financial Officer | Company Administration | — | 12008 | |
| 7 July 2026, 18:16 | Notification regarding unquoted securities - MYX | Other | — | 06021 | |
| 7 July 2026, 18:16 | Notification regarding unquoted securities - MYX | Other | — | 06021 | |
| 7 July 2026, 18:16 | Notification regarding unquoted securities - MYX | Other | — | 06021 | |
| 7 July 2026, 18:16 | Notification regarding unquoted securities - MYX | Other | — | 06021 | |
| 1 July 2026, 19:38 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 26 June 2026, 19:15 | Mayne Pharma appoints new Non-Executive Director | Company Administration | — | 12001 | |
| 26 June 2026, 19:11 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 19 June 2026, 00:57 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 6 June 2026, 01:51 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 5 June 2026, 20:44 | Mayne Pharma receives $14.4m for legal costs from Cosette | Periodic Reports | MS | 03014, 14003 | |
| 5 June 2026, 03:17 | MYX Jefferies Global Healthcare Conference Presentation | Presentations | — | 03026 | |
| 1 June 2026, 18:50 | New DistributeRx partnership with Resilia Pharmaceuticals | Company Update | — | 11001 | |
| 27 May 2026, 18:44 | Mayne Pharma to present at Jefferies Healthcare Conference | Company Administration | — | 12008 | |
| 22 May 2026, 21:08 | Court awards MYX $13.27m for legal costs from Cosette | Company Administration | MS | 14003 | |
| 18 May 2026, 18:57 | Mayne Pharma announces expansion of Adelaide Apothecary | Company Update | — | 11001 | |
| 7 May 2026, 19:14 | Mayne Pharma 3Q investor presentation | Presentations | — | 03026 | |
| 5 May 2026, 03:25 | Notification of cessation of securities - MYX | Other | — | 06027 | |
| 30 Apr 2026, 18:22 | Further details re equity instruments to be issued to CEO | Company Administration | — | 06009, 12008 | |
| 29 Apr 2026, 19:33 | Mayne Pharma reports unaudited 3Q FY26 results | Periodic Reports | MS | 03014 | |
| 7 Apr 2026, 19:41 | MYX expects no material impact from US s232 tariffs | Company Administration | — | 12008 | |
| 2 Apr 2026, 23:33 | Non-Executive Director retirement and recruitment | Company Administration | — | 12001 | |
| 1 Apr 2026, 03:38 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 28 Mar 2026, 03:46 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 25 Mar 2026, 22:12 | Mayne Pharma ASX SMIDcaps conference presentation | Presentations | — | 03026 | |
| 25 Mar 2026, 04:32 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 24 Mar 2026, 03:45 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 17 Mar 2026, 20:00 | Mayne Pharma to present at ASX SMIDcaps Conference | Presentations | — | 12008, 14014 | |
| 11 Mar 2026, 20:22 | DistributeRx Launch Investor Presentation | Presentations | — | 03026, 14014 | |
| 10 Mar 2026, 21:05 | Mayne Pharma launches DistributeRx in the US | Company Update | — | 11001, 14014 | |
| 10 Mar 2026, 05:01 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 7 Mar 2026, 04:05 | S&P DJI Announces March 2026 Quarterly Rebalance | Other | MS | — | |
| 3 Mar 2026, 19:26 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 3 Mar 2026, 05:40 | Ceasing to be a substantial holder from MUFG | Substantial Holders | — | 02003 | |
| 3 Mar 2026, 01:39 | Final Director's Interest Notice (x2) | Director Interests | — | 02010 | |
| 28 Feb 2026, 04:56 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 24 Feb 2026, 05:56 | Proposed issue of securities - MYX | Securities Administration | — | 06013 | |
| 24 Feb 2026, 05:51 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 23 Feb 2026, 20:38 | 2026 Half Year Investor Presentation | Financial Results | MS | 03004, 03026 | |
| 23 Feb 2026, 20:35 | 2026 Half Year Media Release | Financial Results | MS | 03004 | |
| 23 Feb 2026, 20:34 | Half Yearly Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 |
1–50 of 117
1 / 3